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Abstract
Dendritic cells (DC) play a pivotal regulatory role in activation of both the innate as well as the adaptive immune system by
responding to environmental microorganisms. We have previously shown that Lactobacillus acidophilus induces a strong
production of the pro-inflammatory and Th1 polarizing cytokine IL-12 in DC, whereas bifidobacteria do not induce IL-12 but
inhibit the IL-12 production induced by lactobacilli. In the present study, genome-wide microarrays were used to investigate
the gene expression pattern of murine DC stimulated with Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9. L.
acidophilus NCFM strongly induced expression of interferon (IFN)-b, other virus defence genes, and cytokine and chemokine
genes related to the innate and the adaptive immune response. By contrast, B. bifidum Z9 up-regulated genes encoding
cytokines and chemokines related to the innate immune response. Moreover, B. bifidum Z9 inhibited the expression of the
Th1-promoting genes induced by L. acidophilus NCFM and had an additive effect on genes of the innate immune response
and Th2 skewing genes. The gene encoding Jun dimerization protein 2 (JDP2), a transcription factor regulating the
activation of JNK, was one of the few genes only induced by B. bifidum Z9. Neutralization of IFN-b abrogated L. acidophilus
NCFM-induced expression of Th1-skewing genes, and blocking of the JNK pathway completely inhibited the expression of
IFN-b. Our results indicate that B. bifidum Z9 actively inhibits the expression of genes related to the adaptive immune
system in murine dendritic cells and that JPD2 via blocking of IFN-b plays a central role in this regulatory mechanism.
Citation: Weiss G, Rasmussen S, Nielsen Fink L, Jarmer H, Nøhr Nielsen B, et al. (2010) Bifidobacterium bifidum Actively Changes the Gene Expression Profile
Induced by Lactobacillus acidophilus in Murine Dendritic Cells. PLoS ONE 5(6): e11065. doi:10.1371/journal.pone.0011065
Editor: Alma Zernecke, Universita ¨tW u ¨rzburg, Germany
Received February 10, 2010; Accepted May 12, 2010; Published June 10, 2010
Copyright:  2010 Weiss et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the Danish Ministry of Food, Agriculture and Fisheries, and The Danish Food Industry Agency (J.nr.3304-FSE-06-0501-1;
www.dffe.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hafr@life.ku.dk
Introduction
Dendritic cells (DC) are involved in the initiation of both the
innate and adaptive immunity. Pattern recognition receptors
expressed on DC and other immune cells contribute to the specific
recognition of pathogens as well as harmless microorganisms, e.g.
commensals [1], and are thus involved in the subsequent
expression of specific genes. Upon encountering of microorgan-
isms, DC orchestrate an innate and, in most cases, a simultaneous
adaptive immune response [2,3].
Probiotic bacteria can be classified in two groups: strong and
weak inducers of the pro-inflammatory cytokines IL-12 and
tumour necrosis factor (TNF)-a. Co-incubation experiments
indicate that there are clear interactions between the signals
delivered by bacterial strains. Bifidobacteria, which are weak IL-
12 inducers, are able to significantly inhibit the IL-12 production
of strong IL-12 inducers like lactobacilli [4,5]. Interleukin-12-
directs a Th1 adaptive immune response, while the induction of a
Th2 directed response, although less well-described, is believed to
involve DC-derived IL-6 and IL-33 [6,7]. Almost all lactobacilli
and bifidobacteria strains are able to induce significant levels of the
anti-inflammatory cytokine IL-10 in DC, however, there are
considerable variations in the concentrations measured [5,8,9].
The cytokine IL-10 is important for induction of regulatory T
cells [10]. Besides the production of cytokines important for
the activation of various immune cell subsets, production of
chemokines is indispensable for recruitment of specific immune
cells. Some chemokines attract in particular T cells, some also
monocytes and macrophages, while others specifically recruit cells
of the innate immune system, in particular neutrophils [11].
Induction of IL-12 in DC, together with the up-regulation of
surface markers such as MHCII, CD86 and CD40, stimulates
activation of Th1 cells, but is also important for the production of
IFN-c by NK cells [4]. IL-12 is at least partly induced by
interferon (IFN)-b, a key inducer of a strong adaptive immune
response against virus infections initiating a signaling cascade that
controls the expression of hundreds of interferon-stimulated genes
(ISGs) involved in an innate host response against viruses [12].
Several in vivo and in vitro studies have shown that up-regulation of
IFN-b entails a strong Th1 inducing capacity [13]. In DC, IFN-b
functions in an autocrine manner through the IFN-a/b receptor
(IFNAR) inducing transcription of genes involved in different
functions of the cell, such as migration and activation [14]. This
includes genes involved in attraction of cells of both the innate and
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including IL-12 [14]. Whether the transcription of all genes
involved in cellular attraction and migration of DC is induced by
type I interferons remains to be established.
The precise cellular mechanisms involved in the induction of
IFN-b production in DC upon bacterial stimulation are not fully
understood. Only recently it has been established that not only
vira, but also some bacteria can induce a strong IFN-b production.
This includes several Gram-negative bacteria, such as Salmonella
enterica serovar typhimurium, Shigella flexneri and Escherichia spp.,
[15] as well as Gram-positive bacteria, such as Streptococcus spp.
[16–18], and Listeria monocytogenes [19,20]. Upon viral infection,
activation of the gene encoding IFN-b critically depends on
cooperative interaction of the DNA-binding domains of ATF-2/c-
Jun and the immune regulatory factor (IRF)-3 [21]. ATF-2 and c-
Jun are members of the large basic-region leucine zipper family of
transcription factors, constituting the AP-1 transcription factor
complex, which are activated by phosphorylation via mitogen-
activated protein kinases (MAPK). Whereas ATF-2 is activated by
both the p38 and JNK MAPK, c-Jun is only phosphorylated by
JNK [22]. Whether the same mechanism is involved in bacterial
induction of IFN-b in DC remains to be described.
The aim of the present work was to elucidate the molecular
mechanisms by which B. bifidum Z9 is able to inhibit the immune
response in murine bone marrow-derived DC initiated by
L. acidophilus NCFM. Microarrays of DCs stimulated with either
L. acidopilus NCFM or B. bifidum Z9 alone or a mixture of the two
bacteria were performed. In DCs incubated with L. acidophilus
NCFM, genes related to the innate and adaptive immune system
triggering a pro-inflammatory and antiviral response were
significantly up-regulated. When the two strains were used in
combination, B. bifidum Z9 exerted both additive and inhibitory
effects, as the expression of genes initiating the adaptive immune
response induced by L. acidophilus NCFM was strongly inhibited,
whereas genes of the innate immune response were significantly
induced. Our results indicate that the JNK pathway is essential for
the expression of IFN-b induced by a bacterial stimulus. In this
context, the gene encoding Jun dimerization protein 2 (JDP2) was
only up-regulated in cells stimulated with B. bifidum Z9 and is
therefore a candidate gene for the inhibition of IFN-b transcrip-
tion in L. acidophilus NCFM stimulated DC.
Materials and Methods
Bacterial Strains, Growth Conditions and Preparation of
UV-killed Bacteria
The strains Lactobacillus acidophilus NCFM (Danisco, Copenha-
gen, Denmark) and Bifidobacterium bifidum Z9 (Copenhagen
University, Faculty of Life Sciences, Denmark) were grown
anaerobically overnight at 37uC in de Man Rogosa Sharp (MRS)
broth (Merck, Darmstadt, Germany) and sub-cultured twice.
Cells were harvested by centrifugation at 2,0006g for 15 min,
washed twice in phosphate-buffered saline (PBS, Cambrex Bio
Whittaker, East Rutherford, NJ, USA) and re-suspended in 1/10
the growth volume of PBS. As UV-killed bacteria display the
same stimulatory pattern as live bacteria, UV-killed bacteria
were used to avoid the risk of growth during stimulation of DC
and to secure high repeatability by the use of the same batch of
bacteria. The bacteria were killed by 20 min exposure to UV
light and stored at 280uC. Killing was verified by plating the
UV-exposed bacteria on MRS plates. To determine the bacterial
concentration, 3 ml of the preparations were lyophilised as
triplicates and the dry weight was corrected for buffer salt
content.
Generation of Murine Dendritic Cells
Bone marrow-derived DCs were prepared as described previ-
ously [23]. Briefly, bone marrow from three male C57BL/6 mice
(Tactonic, Lille Skensved, Denmark) was flushed out from the
femur and tibia and washed. 3610
5/ml bone marrow cells were
seeded into 10 cm Petri dishes in 10 ml RPMI 1640 (Sigma-
Aldrich, St. Louis, MO, USA) containing 10% (v/v) heat-
inactivated fetal calf serum supplemented with penicillin (100 U/
ml), streptomycin (100 mg/ml), glutamine (4 mM), 50 mm2 -
mercaptoethanol (all purchased from Cambrex Bio Whittaker)
and 15 ng/ml murine GM-CSF (harvested from a GM-CSF
transfected Ag8.653 myeloma cell line). The cells were incubated
for 8 days at 37uCi n5 %C O 2 humidified atmosphere. On day 3,
10 ml of complete medium containing 15 ng/ml GM-CSF was
added. On day 6, 10 ml were removed and replaced by fresh
medium. Non-adherent, immature DC were harvested on day 8.
Stimulation of Murine Dendritic Cells with Bacteria
Immature DC (2610
6 cells/ml) were resuspended in fresh
medium supplemented with 10 ng/ml GM-CSF, and 500 ml/well
were seeded in 48-well tissue culture plates (Nunc, Roskilde,
Denmark). Lactobacillus acidophilus NCFM was added in a final
concentration of 10 mg/ml and Bifidobacterium bifidum Z9 in a final
concentration of 40 mg/ml (both individually and in combination;
total volume 100 ml/well). Optimal bacterial concentrations were
determined in a previous study [24]. The cell cultures were
incubated at 37uCi n5 %C O 2. In the MAPK inhibitor
experiments, DC (2610
6 cells/ml) were pre-incubated for 1 h
with SP600125, a specific inhibitor of JNK1/2 (Invivogen, San
Diego, CA, USA), SB203580, a specific inhibitor of p39 MAPK
(Invivogen), and the MEK1/2 inhibitor U0126 which blocks
MEK1/2 and thereby phosphorylation of the target ERK1/2
(Cell Signaling, MA, USA). For the IFN-b inhibition assay, mouse
IFN-b polyclonal antibody (R&D Systems, Minneapolis, USA) was
added to the DC (10 mg/ml and 50 mg/ml) immediately after
addition of L. acidophilus NCFM (10 mg/ml). Unless indicated
otherwise, DC were harvested for RNA extraction after 10 h and
the supernatant for ELISA analysis after 20 h.
RNA Extraction
Murine DC were harvested after 4 h and 10 h of stimulation,
homogenised by QIAshredder (Qiagen, Ballerup, Denmark), and
RNA was extracted using the RNeasy Plus Mini Kit (Qiagen).
RNA quality was verified by Bioanalyzer (Agilent, Santa Clara,
USA), and the concentration was determined by Nanodrop
(Thermo, Wilmington, USA).
Microarray Analysis
RNA was extracted per stimulation representing DC from three
C57BL/6 mice incubated for 10 h with either Lactobacillus
acidophilus NCFM or Bifidobacterium bifidum Z9 or with both bacteria
in combination. RNA from unstimulated DC was included as a
negative control. 1 mg RNA was converted into cDNA, and biotin-
labeled aRNA was synthesized using the MessageAmp
TM II-Biotin
Enhanced Kit (Ambion, Austin, TX, USA) according to the
manufacturer’s instructions. The Gene Chip Mouse genome 430
2.0 Array (Affymetrix, Santa Clara, CA, USA) comprising 45,000
probe sets representing over 34,000 mouse genes was applied. The
arrays were stained, washed and scanned according to the
manufacturer’s instructions. The microarray data was analyzed
using R and Bioconductor [25]. Raw probe intensities were
normalized using qspline and expression index calculations were
performed using rma [26,27]. For statistical testing, a two-way
Gene Expression in DC
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estimated using a Monte Carlo approach. The statistical
significance was set at an FDR of 0 yielding 1924, 1264 and
490 significantly up-regulated genes (Ensembl 56) upon stimula-
tion with L. acidophilus NCFM and B. bifidum Z9 and both strains
combined, respectively. Gene Set Enrichment (GSEA) was
performed applying the method described by Kim and Volsky
[28] in R using the PGSEA package (Kyle Furge and Karl Dykema
(2006). PGSEA: Parametric Gene Set Enrichment Analysis, R
package version 1.10.0). For this analysis only genes with an
absolute fold change greater than 2 were included.
Quantitative Real Time PCR Analysis
1 mg of total RNA was reverse transcribed by the TaqMan
Reverse Transcription Reagent kit (Applied Biosystems, Foster
City, USA) using random hexamer primers according to the
manufacturer’s instructions. The obtained cDNA was stored in
aliquots at 280uC. The following TaqMan Gene Expression
Assays were purchased (Applied Biosystems): Cxcl1 (Assay ID
Mm00433859_m1), Cxcl2 (Assay ID Mm00436450_m1), Cxcl10
(Assay ID Mm00445235_m1) and Ccl12 (Assay ID
Mm01617100_m1), IL1b (Assay ID Mm00434228_m1). For the
selection of other primers and probes, the regions coding for the
genes investigated were retrieved from the GenBank and EMBL
databases. The following gene sequences were applied: IFN-b
(NM_010510), IL-12 p40 (NM_008352), IL-10 (NM_010548) and
beta actin (NM_007393). Primers and probes were designed using
the software Primer Express 3.0 (Applied Biosystems) and tested
for specificity by the basic alignment search tool BLAST. HPLC
purified forward and reverse primers were manufactured by DNA
Technology (Aarhus, Denmark). The probes were labelled with
the 59 reporter dye 6-carboxy-fluorescein (FAM) and the 39
quencher dye NFQ-MGB (Applied Biosystems). Sequences of
primers and probes are listed in Table 1. Primer and probe
concentrations were optimized and to determine the efficiency of
the amplifications, dilution standard curves were made for each set
of primers and probe (data not shown). The amplifications were
carried out in a total volume of 20 ml containing 16TaqMan
Universal PCR Master Mix (Applied Biosystems), forward and
reverse primer (concentration 900 nM each), 200 nM TaqMan
MGB probe, and purified target cDNA. The cycling parameters
were initiated by 20 sec at 95uC, followed by 40 cycles of 3 sec at
95uC and 30 sec at 60uC using the ABI Prism 7500 (Applied
Biosystems). Amplification reactions were performed in triplicate,
and DNA contamination controls were included. The amplifica-
tions were normalised to the expression of the beta actin encoding
gene. Relative transcript levels were calculated applying the
equation described by Pfaffl et al. [29].
Cytokine Quantification by ELISA
The production of murine IFN-b, IL-12(p70), IL-10, IL-6, IL-
1b and TNF-a was analysed using commercially available
enzyme-linked immunosorbent assay kits (R&D Systems, Minnea-
polis, USA).
Statistical Analysis
One-way ANOVA and Bonferroni tests were applied to analyse
the real-time PCR gene expression data. Statistical calculations
were performed using the software program GraphPad Prism 5
(La Jolla, CA, USA).
Results
Inhibitory and Additive Effects of B. bifidum Z9 on the
Gene Expression in Murine Dendritic Cells are Time
dependent
Our previous finding that some probiotic bacteria strains can
inhibit the stimulatory effects of others led us to compare the gene
expression of DC stimulated with both L. acidophilus NCFM and B.
bifidum Z9 simultaneously. To determine the optimal inhibitory
effect on the IL-12 production, B. bifidum Z9 was added in
increasing concentrations from 0–100 mg/ml to DC stimulated
with 10 mg/ml L. acidophilus NCFM (Figure 1A). The combination
of 40 mg/ml B. bifidum Z9 and 10 mg/ml L. acidophilus NCFM
inhibited the IL-12 production by 69% and was used in all further
experiments. Figure 1B demonstrates that B. bifidum Z9 exerts
inhibitory and additive effects on the gene expression in murine
DC stimulated with L. acidophilus NCFM in a time dependent
manner. A distinct up-regulation of the pro-inflammatory cytokine
Il12 was detected in murine DC after 4 h of incubation with L.
acidophilus NCFM and B. bifidum Z9, as well as with both strains in
combination. However, whereas the expression of Il12 decreased
in B. bifidum Z9 stimulated DC at 10 h, it increased in L. acidophilus
NCFM stimulated cells. In DC stimulated with both strains, Il-12
was down-regulated by 45% at 10 h compared to cells stimulated
with L. acidophilus NCFM alone. In the case of the anti-
inflammatory cytokine Il10, a distinct up-regulation in DC upon
stimulation with L. acidophilus NCFM and B. bifidum Z9 was first
detected at 10 h. With both strains in combination, a significant
additive effect on Il10 (171%) compared to DC stimulated with L
acidophilus NCFM alone was detected at 10 h.
Microarray Analysis reveals Induction of Differential
Groups of Genes by L. acidophilus NCFM and B. bifidum
Z9
To further analyze the differences in gene expression in DC
upon stimulation with either of the two bacteria or both strains in
combination, we performed genome wide microarray analysis of
DC harvested 10 h after stimulation. 341 genes were significantly
up-regulated by more than two-fold upon L. acidophilus NCFM
stimulation, 157 upon B. bifidum Z9 stimulation, and of these, 145
genes were common for both strains (Figure 2). Likewise, 281
genes were significantly down-regulated by more than two fold
upon stimulation with L. acidophilus NCFM, 186 genes upon
Table 1. Primers and Probes used for Real-Time PCR Analysis.
Target
Primers and
Probes Sequence (59-39)
IFN-b (NM_010510) Forward CGGACTTCAAGATCCCTATGGA
Reverse TGGCAAAGGCAGTGTAACTCTTC
Probe ATGACGGAGAAGATGC
IL-12 p40 (NM_008352) Forward TGGAGCACTCCCCATTCCT
Reverse TGCGCTGGATTCGAACAA
Probe CTTCTCCCTCAAGTTC
IL-10 (NM_010548) Forward GATGCCCCAGGCAGAGAA
Reverse CACCCAGGGAATTCAAATGC
Probe CATGGCCCAGAAAT
Beta actin (NM_007393) Forward CGATGCCCTGAGGCTCTTT
Reverse TGGATGCCACAGGATTCCA
Probe CCAGCCTTCCTTCTT
doi:10.1371/journal.pone.0011065.t001
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induced in DC stimulated with both strains simultaneously. The
data generated are deposited in NCBI’s Gene Expression
Omnibus (PMID: 11752295) and are accessible through GEO
Series accession number GSE20302. A Parametric Gene Set
Enrichment (PGSEA) of GO terms revealed that the responses of
the DCs upon stimulation with L. acidophilus NCFM and B. bifidum
Z9 were similar (Fig. 2B). ‘‘Response to virus’’ was the only
GO term enrichment significantly higher up-regulated (P-
value=0.003) in DC stimulated with L. acidophilus NCFM
compared to DC stimulated with B. bifidum Z9. Detailed study
of the expression of individual genes revealed that L. acidophilus
NCFM induced a pro-inflammatory response with a Th1 skewing
profile. By contrast, B. bifidum Z9 induced a more Th2 skewed
response and mainly up-regulated genes related to the innate
immune response (Table 2, 3, 4 and 5).
One of the main differences observed comparing the stimula-
tory patterns of L. acidophilus NCFM and B. bifidum Z9 was the
induction of chemokine encoding genes (Table 2 and 3). A clear
trend towards an up-regulation of chemokines involved in
attraction of Th1 cells (Cxcl9, Cxcl10 and Cxcl11) and/or
monocytes/macrophages (Ccl3, Ccl4, Ccl7 and Ccl12) upon
stimulation with L. acidophilus NCFM emerged, whereas B. bifidum
Z9 gave rise to a much lower gene induction of Th1 recruiting
chemokines (55% reduction of Cxcl9, 44% reduction of Cxcl10
and 73% reduction of Cxcl11 compared to DC stimulated with
L. acidophilus NCFM). The gene expression of the monocytes/
macrophages attracting chemokines was likewise much lower,
from no up-regulation (Ccl4) to approximately 50% of the up-
regulation (Ccl3, Ccl4 and Ccl7) detected after stimulation with
L. acidophilus. In contrast, stimulation of DC with B. bifidum Z9
resulted in the highest up-regulation of chemokines involved in the
attraction of neutrophils (Cxcl1, Cxcl2, and Cxcl5), although these
genes were also up-regulated, yet to a lower extent, in L. acidophilus
NCFM stimulated cells (70–80% up-regulation compared to
B. bifidum Z9 stimulated cells).
When both strains were added in combination, B. bifidum Z9
exerted inhibitory effects on the expression of the Th1 attracting
chemokines induced by L. acidophilus NCFM (Cxcl9, Cxcl10 and
Cxcl11) and additive effects on the neutrophil recruiting chemo-
kines mostly induced by B. bifidum Z9 (Cxcl1, Cxcl2, and Cxcl5). It
can be concluded that co-stimulation of DC with L. acidophilus
NCFM and B. bifidum Z9 has a significant inhibitory effect on the
gene expression of chemokines leading to an abrogation of the
pro-inflammatory and Th1 polarizing response induced by
L. acidophilus NCFM. In analogy with the neutrophil attracting
chemokine profiles, B. bifidum Z9 strongly induced, and further-
more had an additive effect on the L. acidophilus NCFM-induced
expression of the gene encoding granulocyte colony-stimulating
factor (G-CSF), which is important for the proliferation and
differentiation of neutrophil precursors and mature neutrophils
[30] (data not shown). Gene expression results obtained by
Figure 1. Inhibitory and additive effects of Bifidobacterium bifidum Z9. A. The inhibitory effect of B. bifidum Z9 on the IL-12 production of L.
acidophilus NCFM stimulated dendritic cells was determined by ELISA testing various concentrations of B. bifidum Z9 (0–100 mg/ml) against a
constant concentration of L. acidophilus NCFM (10 mg/ml). B. B. bifidum Z9 exerts inhibitory effects on the expression of Il12 and additive effects on
the expression of Il10 in L. acidophilus NCFM stimulated dendritic cells in a time dependent manner. Gene expression was measured by RT-PCR 4 h
and 10 h after stimulation with the indicated bacteria (L. acidophilus NCFM versus L. acidophilus NCFM+B. bifidum Z9 P,0.01). Data show results from
one out of five independent experiments.
doi:10.1371/journal.pone.0011065.g001
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Cxcl2 by Real-Time PCR (Figure 3). With both strains in
combination, B. bifidum Z9 significantly down-regulated the
L. acidophilus NCFM induced expression of the Th1 attracting
chemokine Cxcl10 by 90% and the expression of the monocyte and
macrophage recruiting chemokine Ccl12 by 85%, whereas the
Figure 2. Microarray analysis of dendritic cells stimulated with Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9. Up- and
downregulation of genes upon incubation of dendritic cells with L. acidophilus NCFM and B. bifidum Z9, respectively, and both strains in combination.
A. Venn diagram depicting the distinct up- and down regulation and overlap of genes. Only genes with an absolute fold change greater than 2 were
included. B. Parametric Gene Set Enrichment of Gene Ontology (GO) Biological Process terms of the top 30 most significant GO terms comparing L.
acidophilus NCFM vs. control (no stimulation). Blue indicates repression of the genes, white indicates no change and red indicates induction of the
genes in the GO term. Only the GO term ‘‘response to virus’’ was significantly different (*) when comparing L. acidophilus NCFM and B. bifidum Z9
responses.
doi:10.1371/journal.pone.0011065.g002
Table 2. Inhibitory Effects of Bifidobacterium bifidum Z9 on the Chemokine Expression in Lactobacillus acidophilus NCFM
stimulated Dendritic Cells.
Ensembl Gene Nr. Annotation L. acidophilus B. bifidum L. acidophilus + B. bifidum Name
00000029417 Cxcl9 4.0 1.8 2.2 CXC ligand 9
00000034855 Cxcl10 5.2 2.9 4.3 CXC ligand 10
00000060183 Cxcl11 3.6 0.96 2.2 CXC ligand 11
00000000982 Ccl3 1.0 0.61 0.75 CC ligand 3
00000018930 Ccl4 1.1 0.075 0.63 CC ligand 4
00000035373 Ccl7 2.8 1.5 2.3 CC ligand 7
00000035352 Ccl12 2.8 0.86 1.0 CC ligand 12
Data indicates gene expression fold changes of dendritic cells stimulated with L. acidophilus NCFM, B. bifidum Z9 and both strains in combination in comparison with
un-stimulated dendritic cells measured on Affymetrix microarrays. Foldchanges are log2 relative to control.
doi:10.1371/journal.pone.0011065.t002
Gene Expression in DC
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comparison to B. bifidum Z9 alone). With both strains in
combination, the chemokine Cxcl2 was expressed at a lower level
which is comparable to the level of Cxcl2 expressed by DC
stimulated with B. bifidum Z9 alone.
Also regarding the expression of cytokine genes, a clear
distinction between the two stimulation regimes was observed
(Table 4 and 5). The pro-inflammatory and/or Th1 inducing
cytokine genes Ifnb1, Il12, Il18, and Tnf were strongly up-
regulated only in L. acidophilus NCFM stimulated DC, whereas B.
bifidum Z9 strongly up-regulated the cytokines Il10, Il15, Il1b and
Il33. Thus, when DC were stimulated with both strains
simultaneously, the inhibitory pattern was similar to the one
observed for chemokines, as the pro-inflammatory cytokine genes
induced by L. acidophilus NCFM were significantly down-
regulated. The most definite inhibitory effect of B. bifidum Z9
was detected for the gene encoding IFN-b, as it was down-
regulated by 81%. In contrast, simultaneous stimulation with the
two bacteria led to a higher expression of Il10, Il15, Il1b and Il33
compared to DC stimulated with B. bifidum Z9 alone. The
strongest additive effect upon co-stimulation with the two bacteria
was detected for Il33, a cytokine important for the activation of
NFkB, MAPK kinases, and the production of Th2-associated
cytokines [7].
Interestingly, microarray analysis revealed that only B. bifidum
Z9 was able to down-regulate the expression of the genes induced
by L. acidophilus NCFM in murine DC. This effect was not
observed vice versa. The induction of the cytokines Ifnb1, Il12, Il10
and Ilb1 was confirmed both on gene level by RT-PCR (data not
shown) and protein level by ELISA (Figure 4).
IFN-b is a Key Inducer of the Pro-inflammatory and Th1
Polarizing Response
Upon stimulation of DC, L. acidophilus NCFM induced a
distinct up-regulation of IFN-b, the key inducer of anti-viral
responses, leading to the activation of multiple interferon-
stimulated genes (ISGs) involved in the innate host response
against viruses. We therefore hypothesized that the onset of the
pro-inflammatory response initiated by L. acidophilus NCFM is
dependent on IFN-b. We determined the expression of the gene
encoding IFN-b over time (2 h, 4 h and 10 h) in DC stimulated
with L. acidophilus NCFM and B. bifidum Z9, respectively
( F i g u r e5 A ) .W h e nD Cw e r ei n c u b a t e dw i t hL. acidophilus
NCFM, the gene encoding IFN-b was only slightly up-regulated
after 2 h (38-fold), but reached a significant maximum after 4 h
(589-fold) that declined to 100-fold after 10 h. By contrast,
stimulation of DC with B. bifidum Z9 only gave rise to a slight up-
regulation of the gene encoding IFN-b at 2 h, which was down-
regulated again after 4 h. To investigate whether the induction
of the chemokines Cxcl10 and Ccl12 is dependent on IFN-b,w e
added polyclonal anti-IFN-b antibodies to the DC immediately
after addition of L. acidophilus NCFM and measured the gene
expression profiles of Cxcl10 and Ccl12 at 10 h. In the case of the
chemokine Cxcl10, the very strong expression of the gene was
completely abrogated when polyclonal anti-IFN-b antibodies
were added (Figure 5B). The same pattern was observed for the
gene encoding the chemokine Ccl12 (Figure 5C). The inhibition
of the expression of Cxcl10 was confirmed on the protein level by
ELISA, as the addition of 10 mg/ml polyclonal IFN-b antibodies
completely inhibited the protein production of Cxcl10
(Figure 5D).
Table 3. Additive Effects of Bifidobacterium bifidum Z9 on the Chemokine Expression in Lactobacillus acidophilus NCFM stimulated
Dendritic Cells.
Ensembl Gene Nr. Annotation L. acidophilus B. bifidum L. acidophilus + B. bifidum Name
00000029380 Cxcl1 3.2 4.5 4.7 CXC ligand 1
00000058427 Cxcl2 1.7 2.3 2.2 CXC ligand 2
00000029371 Cxcl5 3.5 4.2 4.4 CXC ligand 5
Data indicates gene expression fold changes of dendritic cells stimulated with L. acidophilus NCFM, B. bifidum Z9 and both strains in combination in comparison with
un-stimulated dendritic cells measured on Affymetrix microarrays. Foldchanges are log2 relative to control.
doi:10.1371/journal.pone.0011065.t003
Table 4. Inhibitory Effects of Bifidobacterium bifidum Z9 on the Cytokine Expression in Lactobacillus acidophilus NCFM stimulated
Dendritic Cells.
Ensembl Gene Nr Annotation L. acidophilus B. bifidum L. acidophilus + B. bifidum Name
00000048806 Ifnb1 2.5 0.9 0.48 Interferon beta 1
00000004296 Il12b 5.5 4.3 5 Interleukin 12b
00000031712 Il15 2.7 1.8 2.4 Interleukin 15
00000024401 Tnf 2.1 1.3 1.7 Tumor necrosis factor alpha
00000039217 Il18 2.0 1.0 1.4 Interleukin 18
00000025383 Il23a 1.0 0.37 0.68 Interleukin 23a
00000027776 Il12a 0.77 0.6 0.59 Interleukin 12a
Data indicates gene expression fold changes of dendritic cells stimulated with L. acidophilus NCFM, B. bifidum Z9 and both strains in combination in comparison with
un-stimulated dendritic cells measured on Affymetrix microarrays. Foldchanges are log2 relative to control.
doi:10.1371/journal.pone.0011065.t004
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protein 2 (Jdp2)
Our results suggest that B. bifidum Z9 inhibits the up-regulation
of genes induced by L. acidophilus NCFM by actively leading to an
expression of genes involved in the repression of IFN-b.
Microarray analysis revealed that only few genes were significantly
induced by B. bifidum Z9. One of these genes, which encodes Jun
dimerization protein 2 (JDP2), is of special interest. JDP2 is a basic
leucine zipper transcription factor family member that interacts
with the transcription factors c-Jun and ATF2, leading to
inhibition of their transcription-promoting activities, and thus
plays a major role in the regulation of cell signaling. In contrast to
homodimers of c-Jun and heterodimers of c-Jun and ATF2, JDP2
forms heterodimers with c-Jun and ATF2 and acts as a repressor
at the AP-1 site [31]. Thus, JDP2 blocks the transcription of genes
otherwise expressed upon MAPK phosphorylaton of c-Jun and
other AP-1 subunits. Our microarray analysis revealed that Jpd2
was induced in DC upon stimulation with B. bifidum Z9 (1.6-fold)
Table 5. Additive Effects of Bifidobacterium bifidum Z9 on the Cytokine Expression in Lactobacillus acidophilus NCFM stimulated
Dendritic Cells.
Ensembl Gene Nr Annotation L. acidophilus B. bifidum L. acidophilus + B. bifidum Name
00000016529 Il10 2.5 3.0 3.6 Interleukin 10
00000025746 Il6 4.0 5.0 5.1 Interleukin 6
00000027399 Il1a 2.2 2.3 2.4 Interleukin 1 alpha
00000027398 Il1b 2.1 2.3 2.3 Interleukin 1 beta
00000024810 Il33 0.76 1.8 2.3 Interleukin 33
Data indicates gene expression fold changes of dendritic cells stimulated with L. acidophilus NCFM, B. bifidum Z9 and both strains in combination in comparison with
un-stimulated dendritic cells measured on Affymetrix microarrays. Foldchanges are log2 relative to control.
doi:10.1371/journal.pone.0011065.t005
Figure 3. Induction of chemokines in Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9 stimulated dendritic cells. Gene
expression analysis of the chemokines Cxcl10, Ccl12, Cxcl1 and Cxcl2 in dendritic cells upon stimulation with L. acidophilus NCFM, B. bifidum Z9 or the
two bacteria in combination and unstimulated dendritic cells (control) was performed by RT-PCR after 10 h of stimulation (L. acidophilus NCFM+B.
bifidum Z9 versus L. acidophilus NCFM, P,0.01).
doi:10.1371/journal.pone.0011065.g003
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lower extent upon stimulation with L. acidophilus NCFM alone
(0.49-fold). This induction of Jpd2 was verified by RT-PCR
(Fig 6A).
MAPK JNK Kinase directs the Activation of the Immune
System in L. acidophilus NCFM stimulated Dendritic Cells
As the induction of Jdp2 may be implicated in the suppression of
IFN-b and other cytokines up-regulated by L. acidophilus NCFM,
but down-regulated by B. bifidum Z9, we hypothesized that the
MAP kinases p38 and JNK, but not ERK, are involved in the
expression of these cytokines. Our next approach was therefore to
use MAPK kinase inhibitors (blocking MAPK p38, JNK1/2, and
MEK1/2) to test this hypothesis. As demonstrated in figure 6B,
blocking of the JNK1/2 pathway completely inhibited the protein
expression of IFN-b in DC stimulated with L. acidophilus NCFM,
whereas blocking of p38 only resulted in a partial inhibition (73%).
Blocking of ERK phosphorylation by the MEK1/2 inhibitor did
not affect the IFN-b expression induced by L. acidophilus NCFM.
The same pattern emerged for Cxcl10 (Fig. 6B) as well as for TNF-
a (data not shown). The production of IL-12 was significantly
inhibited by all 3 MAPK kinase inhibitors (Fig. 6B). Hence, as
JNK activates the transcription factors c-Jun and ATF-2 and is a
prerequisite for the production of IFN-b, the up-regulation of Jdp2
is most likely to affect the activity of c-Jun and ATF-2. This, in
turn, has an impact on the expression of IFN-b through its binding
to their common response element.
We therefore suggest that B. bifidum Z9 actively inhibits the
induction of genes in DC triggering the adaptive immune system
and that JDP2 plays a major role in the regulatory mechanism.
Discussion
It has previously been shown by us and other groups that
different bacteria considered as beneficial for our health have
highly varying effects on the cells of the immune system, including
DC, and that a combination of bacteria exerts inhibitory or
additive effects [4,5,9,23]. In the present study we used genome
wide microarray analysis to further explore this phenomenon and
to elucidate the underlying cellular mechanisms.
First of all, our results indicate that the gene expression after
stimulation is time dependent.
At 4 h, the expression of the cytokine Il12 was similar for the two
bacteria, whereas the expression increased strongly in L. acidophilus
NCFM stimulated DC but decreased in B. bifidum Z9 stimulated
DC. This indicates that activation of kinases may give rise to initial
production of IFN-b and IL-12 in the B. bifidum Z9 stimulated cells,
which is subsequently inhibited by newly expressed genes involved
in a down-regulating mechanism. The microarray analysis revealed
that far more genes were up-regulated in L. acidophilus NCFM
stimulated DC than in B. bifidum Z9 stimulated DC. Most of these
genes induced by L. acidophilus NCFM were down-regulated when
both bacteria were added in combination. Thus, our earlier findings
regarding the differences in production of the pro-inflammatory
cytokines IL-12 andTNF-a inDCsstimulated with eitherofthetwo
bacterial genera [5] can be extended to account for a high number
of genes. A gene set enrichment analysis of GO terms, however,
only revealed that genes related to virus defence were significantly
higher up-regulated after stimulation of DC with L. acidophilus
NCFM compared to stimulation with B. bifidum Z9 or both bacteria
in combination. A further analysis of genes within the GO terms
Figure 4. Induction of cytokines in Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9 stimulated dendritic cells. Protein
expression of cytokines was measured by ELISA in supernatants from dendritic cells after 20 h of stimulation with L. acidophilus NCFM, B. bifidum Z9,
or with both strains in combination. Supernatant from unstimulated DC were used as controls (L. acidophilus NCFM+B. bifidum Z9 versus L.
acidophilus NCFM P,0.01). Results are representative of 2 experiments.
doi:10.1371/journal.pone.0011065.g004
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(interleukins and chemokines) according to the differential stimu-
lation regime, which was not revealed by the gene set enrichment.
Stimulation with L. acidophilus NCFM induced a high number of
genes involved in pro-inflammatory responses, including activation
of the adaptive immune response, e.g. chemokines involved in the
Figure 6. Jdp2 and MAPK kinases control immune responses in dendritic cells. Expression of Jdp2 and inhibition of MAPK kinases in
dendritic cells upon stimulation of L. acidophilus NCFM. A. B. bifidum Z9 exerts an additive effect on the expression of Jdp2 in DC stimulated with L.
acidophilus NCFM at timepoint 10 h measured by RT-PCR (L. acidophilus NCFM+B. bifidum Z9 versus L. acidophilus NCFM, P,0.01). B: Protein
expression of IFN-b, Cxcl10 and IL-12 in murine L. acidophilus NCFM stimulated dendritic cells measured by ELISA in the presence of the MAPK
inhibitors p38, JNK1/2 and MEK1/2 (L. acidophilus NCFM versus inhibitors, P,0.01).
doi:10.1371/journal.pone.0011065.g006
Figure 5. Lactobacillus acidophilus NCFM induces IFN-b in dendritic cells. The IFN-b encoding gene is strongly up-regulated in L .acidophilus
NCFM stimulated dendritic cells and responsible for the expression of the chemokines Cxcl10 and Ccl12. A. Expression of the IFN-b encoding gene
over time in dendritic cells upon stimulation with L. acidophilus NCFM and B. bifidum Z9. B. Inhibition of IFN-b activity induced by L. acidophilus NCFM
by addition of polyclonal IFN-b antibodies measured via the gene expression of the chemokine Cxcl10 after 10 h and C. via the gene expression of
the chemokine Ccl12 after 10 h and D. via protein production of Cxcl10 in the supernatant after 24 h of stimulation by ELISA (P,0.01).
doi:10.1371/journal.pone.0011065.g005
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primarily involved in attraction of cells from the innate immune
system, e.g. neutrophilic granulocytes, monocytes and eosinophilic
granulocytes, were equally up-regulated after stimulation of DC
with L. acidophilus NCFM and B. bifidum Z9, respectively.
Furthermore, the expression of the chemokines strongly up-
regulated by L. acidophilus NCFM was significantly inhibited when
both bacteria were added simultaneously. The same pattern of
inhibition was detected for cytokines involved in the stimulation of
a Th1 response, e.g. IFN-b, IL-12, IL-18 [13,33,34].
Overall, our results show that stimulation of DC with
L. acidophilus NCFM induces a Th1 polarising response, whereas
stimulation of DC with B. bifidum Z9 induces a Th2 response. The
Th2 polarising profile of DC is not well-described in the literature,
but emerging evidence supports that IL-33 and Cxcl1, both up-
regulated by B. bifidum Z9, play a role in the production of Th2-
associated cytokines from in vitro polarized Th2 cells and in
recruitment of Th2 cells to the target tissue of allergic
inflammation [7,35].
Furthermore, we found that chemokines strongly induced by
L. acidophilus NCFM were dependent on the up-regulation and
subsequent autocrine stimulation of IFN-b. We have demon-
strated the same IFN-b dependent mechanism for the gene
coding for the Toll-like receptor 3 (TLR-3) (Weiss et al.,
submitted). Moreover, the expression of a large number of
Th1-promoting genes is known to depend critically on stimula-
tion of the cells with IFN-b [13]. Whether the expression of all
genes up-regulated only by L. acidophilus NCFM and down-
regulated by the simultaneous presence of B. bifidum Z9 is
initiated by IFN-b remains to be elucidated. However, the fact
that the most prominent effector mechanisms involved in the
antiviral defence are controlled by type I IFNs, in particular IFN-
b, indicates that the expression of many genes classified as Th1
inducing may likewise be controlled by IFN-b [14,36]. IFN-b
binds to the type I interferon receptor (IFNAR), an event that
initiates the activation of the associated Janus kinases. This in
turn activates the IFN-stimulated gene factor 3 (ISG3) via
stimulation and heterodimerization of STAT1 and STAT2
[14,37]. The events leading to the expression of the gene
encoding IFN-b upon bacterial stimulation are, at least to some
extent, similar to the viral IFN-b-inducing events. The activation
of IRF3 seems to be a key point [38]. IRF3 is constitutively
expressed in most cells [14], and its phosphorylation is mediated
by inhibitors of nuclear factor (NF)-kB kinases. This leads to an
association of IRF3 with various transcription factors of the AP-1
family, including ATF-2 and c-Jun, to form an enhanceosome
that binds the IFN-b promoter, thus stimulating the expression of
the Ifnb1 gene [39]. This activation of IRF3 is believed to take
place upon activation of TLR4 by Gram negative bacteria
through the same mechanisms found for virus induction of IFN-b
[40]. Whether a corresponding mechanism for induction of IFN-
b upon stimulation with Gram-positive bacteria is existent
remains to be established.
Relatively few genes were exclusively up-regulated in DCs
stimulated with B. bifidum Z9. Notably, the expression of these
genes was not affected by addition of L. acidophilus NCFM. Thus,
whereas B. bifidum Z9 has the capability to actively modulate the
response in DC induced by L. acidophilus NCFM, the opposite
does not apply. The expression of the transcription factor Jdp2
induced in B. bifidum Z9 stimulated DC is of particular interest, as
JDP2 has been shown to bind to cAMP-response element (CRE)
either as a homodimer or a heterodimer with ATF-2 and c-Jun,
allowing JDP2 to repress CRE-dependent transcription [41,42].
ATF-2, and in particular c-Jun, have been shown to stimulate the
production of IFN-b. ATF-2 is activated by both JNK and p38,
but c-Jun is only activated by JNK [22]. In the present study, we
demonstrated that the IFN-b induction is strongly dependent on
JNK activation, as inhibition of JNK, but not p38, almost totally
abrogated the production of IFN-b and also of the expression of
genes and gene products which are dependent on IFN-b,a s
exemplified in our study with Cxcl10. The up-regulation of Jdp2
in DC stimulated with B. bifidum Z9 indicates that this
transcription factor is involved in an active down-regulation of
the transcription of the gene coding for IFN-b by changing the
composition of the dimer binding to CRE in the enhanceosome,
thus inhibiting binding of c-Jun and thereby preventing the
transcription of the gene encoding IFN-b. This finding, in
combination with the kinetics of expression of the genes encoding
IFN-b and IL-12 (Figure 1 and 5), strongly suggests that the up-
regulation of Jdp2 in B. bifidum Z9 DC is possibly involved in the
inhibition of the stimulatory profile induced by L. acidophilus
NCFM.
In conclusion, we present data that reveal highly distinct
immune stimulating properties of the two probiotic strains L.
acidophilus NCFM and B. bifidum Z9. Our results strongly indicate
that B. bifidum Z9 employs an active mechanism down-regulating
the pro-inflammatory and Th1 skewing profile induced by L.
acidophilus NCFM in DC.
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